T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Chemed
CHE
$6.99B
| $2.66M | ﹤0.01% |
28,400
-8,000
| -22% | -$709K |
|
1527
UDR
UDR
$12.2B
| $2.65M | ﹤0.01% |
92,582
+2,800
| +3% | +$75.4K |
|
|
TCS
1528
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.64M | ﹤0.01% |
6,327
+67
| +1% | +$29.2K |
|
1529
Sabra Healthcare REIT
SBRA
$5.11B
| $2.63M | ﹤0.01% |
91,498
-37,100
| -29% | -$1.08M |
|
|
HAWK
1530
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $2.6M | ﹤0.01% |
95,677
+79,077
| +476% | +$1.96M |
|
1531
Toronto Dominion Bank
TD
$204B
| $2.56M | ﹤0.01% |
49,700
+38,544
| +346% | +$1.87M |
|
1532
Crawford & Co Class B
CRD.B
$585M
| $2.55M | ﹤0.01% |
253,128
+4,100
| +2% | +$43.1K |
|
1533
World Acceptance Corp
WRLD
$899M
| $2.49M | ﹤0.01% |
32,800
+2,300
| +8% | +$179K |
|
|
SGI
1534
Somnigroup International
SGI
$13.9B
| $2.48M | ﹤0.01% |
165,824
-15,976
| -9% | -$214K |
|
1535
ResMed
RMD
$32.9B
| $2.46M | ﹤0.01% |
48,616
+3,105
| +7% | +$154K |
|
|
TRLA
1536
DELISTED
TRULIA INC (DEL)
TRLA
| $2.44M | ﹤0.01% |
51,600
| – | – |
|
|
ILG
1537
DELISTED
ILG, Inc Common Stock
ILG
| $2.42M | ﹤0.01% |
110,204
-35,300
| -24% | -$814K |
|
|
GFIG
1538
DELISTED
GFI GROUP INC
GFIG
| $2.41M | ﹤0.01% |
727,173
+6,000
| +0.8% | +$20.8K |
|
1539
Mid-America Apartment Communities
MAA
$15.6B
| $2.41M | ﹤0.01% |
33,032
+5,900
| +22% | +$417K |
|
|
ACTS
1540
DELISTED
Actions Semiconductor Co
ACTS
| $2.39M | ﹤0.01% |
1,003,600
+2,000
| +0.2% | +$4.33K |
|
|
OCR
1541
DELISTED
OMNICARE INC
OCR
| $2.37M | ﹤0.01% |
35,665
+1,462
| +4% | +$90.8K |
|
|
LVLT
1542
DELISTED
Level 3 Communications Inc
LVLT
| $2.33M | ﹤0.01% |
52,977
+2,614
| +5% | +$110K |
|
|
JAH
1543
DELISTED
JARDEN CORPORATION
JAH
| $2.27M | ﹤0.01% |
57,348
-2,376
| -4% | -$90.6K |
|
|
HSH
1544
DELISTED
HILLSHIRE BRANDS CO
HSH
| $2.27M | ﹤0.01% |
36,400
+2,200
| +6% | +$99.4K |
|
1545
Amkor Technology
AMKR
$14.6B
| $2.24M | ﹤0.01% |
200,426
-26,500
| -12% | -$244K |
|
1546
Cabot Corp
CBT
$4.47B
| $2.22M | ﹤0.01% |
38,250
+10,200
| +36% | +$594K |
|
1547
Everest Group
EG
$14.1B
| $2.21M | ﹤0.01% |
13,786
| – | – |
|
1548
UGI
UGI
$7.63B
| $2.18M | ﹤0.01% |
64,740
+5,100
| +9% | +$161K |
|
|
NEWS
1549
DELISTED
NewStar Financial, Inc.
NEWS
| $2.17M | ﹤0.01% |
154,591
-45,200
| -23% | -$576K |
|
|
FLG
1550
Flagstar Bank National Association
FLG
$5.93B
| $2.17M | ﹤0.01% |
45,188
+5,195
| +13% | +$244K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.